Adage Capital Partners Gp, L.L.C. Takeda Pharmaceutical CO LTD Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,433,023 shares of TAK stock, worth $48.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,433,023Holding current value
$48.1 Million% of portfolio
0.1%Shares
5 transactions
Others Institutions Holding TAK
# of Institutions
360Shares Held
67.4MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$185 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$79.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$74.5 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$49.1 Million0.57% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.16MShares$44.2 Million0.08% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...